Selected research
Industry Research
IVIg Liquid Industry Research Report 2026
Market perspective
The global IVIg Liquid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for IVIg Liquid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for IVIg Liquid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of IVIg Liquid include Takeda, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, Octapharma, LFB Group, Kedrion, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global IVIg Liquid market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
IVIg Liquid Market by Company
Takeda
Sichuan Yuanda Shuyang
Shanghai RAAS
Hualan Bio
Octapharma
LFB Group
Kedrion
Grifols
CSL
CNBG
CBPO
BPL
Biotest
IVIg Liquid Segment by Type
50ml
25ml
IVIg Liquid Segment by Application
Autoimmune Disease
Immunodeficiency
Acute Infection
IVIg Liquid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVIg Liquid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of IVIg Liquid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVIg Liquid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of IVIg Liquid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of IVIg Liquid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of IVIg Liquid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50ml
- 25ml
Applications
- Autoimmune Disease
- Immunodeficiency
- Acute Infection
Companies covered
- Takeda
- Sichuan Yuanda Shuyang
- Shanghai RAAS
- Hualan Bio
- Octapharma
- LFB Group
- Kedrion
- Grifols
- CSL
- CNBG
- CBPO
- BPL
- Biotest
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global IVIg Liquid Market Size (2021-2032)
- 2.2.2 Global IVIg Liquid Sales (2021-2032)
- 2.2.3 Global IVIg Liquid Market Average Price (2021-2032)
- 2.3 IVIg Liquid by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50ml
- 2.3.3 25ml
- 2.4 IVIg Liquid by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Autoimmune Disease
- 2.4.3 Immunodeficiency
- 2.4.4 Acute Infection
3 Market Competitive Landscape by Manufacturers
- 3.1 Global IVIg Liquid Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global IVIg Liquid Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global IVIg Liquid Revenue of Manufacturers (2021-2026)
- 3.4 Global IVIg Liquid Average Price by Manufacturers (2021-2026)
- 3.5 Global IVIg Liquid Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of IVIg Liquid, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of IVIg Liquid, Product Type & Application
- 3.8 Global Manufacturers of IVIg Liquid, Established Date
- 3.9 Global IVIg Liquid Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda
- 4.1.1 Takeda Company Information
- 4.1.2 Takeda Business Overview
- 4.1.3 Takeda IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda IVIg Liquid Product Portfolio
- 4.1.5 Takeda Recent Developments
- 4.2 Sichuan Yuanda Shuyang
- 4.2.1 Sichuan Yuanda Shuyang Company Information
- 4.2.2 Sichuan Yuanda Shuyang Business Overview
- 4.2.3 Sichuan Yuanda Shuyang IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sichuan Yuanda Shuyang IVIg Liquid Product Portfolio
- 4.2.5 Sichuan Yuanda Shuyang Recent Developments
- 4.3 Shanghai RAAS
- 4.3.1 Shanghai RAAS Company Information
- 4.3.2 Shanghai RAAS Business Overview
- 4.3.3 Shanghai RAAS IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai RAAS IVIg Liquid Product Portfolio
- 4.3.5 Shanghai RAAS Recent Developments
- 4.4 Hualan Bio
- 4.4.1 Hualan Bio Company Information
- 4.4.2 Hualan Bio Business Overview
- 4.4.3 Hualan Bio IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hualan Bio IVIg Liquid Product Portfolio
- 4.4.5 Hualan Bio Recent Developments
- 4.5 Octapharma
- 4.5.1 Octapharma Company Information
- 4.5.2 Octapharma Business Overview
- 4.5.3 Octapharma IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Octapharma IVIg Liquid Product Portfolio
- 4.5.5 Octapharma Recent Developments
- 4.6 LFB Group
- 4.6.1 LFB Group Company Information
- 4.6.2 LFB Group Business Overview
- 4.6.3 LFB Group IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LFB Group IVIg Liquid Product Portfolio
- 4.6.5 LFB Group Recent Developments
- 4.7 Kedrion
- 4.7.1 Kedrion Company Information
- 4.7.2 Kedrion Business Overview
- 4.7.3 Kedrion IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Kedrion IVIg Liquid Product Portfolio
- 4.7.5 Kedrion Recent Developments
- 4.8 Grifols
- 4.8.1 Grifols Company Information
- 4.8.2 Grifols Business Overview
- 4.8.3 Grifols IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Grifols IVIg Liquid Product Portfolio
- 4.8.5 Grifols Recent Developments
- 4.9 CSL
- 4.9.1 CSL Company Information
- 4.9.2 CSL Business Overview
- 4.9.3 CSL IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 CSL IVIg Liquid Product Portfolio
- 4.9.5 CSL Recent Developments
- 4.10 CNBG
- 4.10.1 CNBG Company Information
- 4.10.2 CNBG Business Overview
- 4.10.3 CNBG IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CNBG IVIg Liquid Product Portfolio
- 4.10.5 CNBG Recent Developments
- 4.11 CBPO
- 4.11.1 CBPO Company Information
- 4.11.2 CBPO Business Overview
- 4.11.3 CBPO IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CBPO IVIg Liquid Product Portfolio
- 4.11.5 CBPO Recent Developments
- 4.12 BPL
- 4.12.1 BPL Company Information
- 4.12.2 BPL Business Overview
- 4.12.3 BPL IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 BPL IVIg Liquid Product Portfolio
- 4.12.5 BPL Recent Developments
- 4.13 Biotest
- 4.13.1 Biotest Company Information
- 4.13.2 Biotest Business Overview
- 4.13.3 Biotest IVIg Liquid Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Biotest IVIg Liquid Product Portfolio
- 4.13.5 Biotest Recent Developments
5 Global IVIg Liquid Market Scenario by Region
- 5.1 Global IVIg Liquid Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global IVIg Liquid Sales by Region: 2021-2032
- 5.2.1 Global IVIg Liquid Sales by Region: 2021-2026
- 5.2.2 Global IVIg Liquid Sales by Region: 2027-2032
- 5.3 Global IVIg Liquid Revenue by Region: 2021-2032
- 5.3.1 Global IVIg Liquid Revenue by Region: 2021-2026
- 5.3.2 Global IVIg Liquid Revenue by Region: 2027-2032
- 5.4 North America IVIg Liquid Market Facts & Figures by Country
- 5.4.1 North America IVIg Liquid Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America IVIg Liquid Sales by Country (2021-2032)
- 5.4.3 North America IVIg Liquid Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe IVIg Liquid Market Facts & Figures by Country
- 5.5.1 Europe IVIg Liquid Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe IVIg Liquid Sales by Country (2021-2032)
- 5.5.3 Europe IVIg Liquid Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific IVIg Liquid Market Facts & Figures by Country
- 5.6.1 Asia Pacific IVIg Liquid Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific IVIg Liquid Sales by Country (2021-2032)
- 5.6.3 Asia Pacific IVIg Liquid Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America IVIg Liquid Market Facts & Figures by Country
- 5.7.1 South America IVIg Liquid Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America IVIg Liquid Sales by Country (2021-2032)
- 5.7.3 South America IVIg Liquid Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa IVIg Liquid Market Facts & Figures by Country
- 5.8.1 Middle East and Africa IVIg Liquid Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa IVIg Liquid Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa IVIg Liquid Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global IVIg Liquid Sales by Type (2021-2032)
- 6.1.1 Global IVIg Liquid Sales by Type (2021-2032) & (k units)
- 6.1.2 Global IVIg Liquid Sales Market Share by Type (2021-2032)
- 6.2 Global IVIg Liquid Revenue by Type (2021-2032)
- 6.2.1 Global IVIg Liquid Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global IVIg Liquid Revenue Market Share by Type (2021-2032)
- 6.3 Global IVIg Liquid Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global IVIg Liquid Sales by Application (2021-2032)
- 7.1.1 Global IVIg Liquid Sales by Application (2021-2032) & (k units)
- 7.1.2 Global IVIg Liquid Sales Market Share by Application (2021-2032)
- 7.2 Global IVIg Liquid Revenue by Application (2021-2032)
- 7.2.1 Global IVIg Liquid Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global IVIg Liquid Revenue Market Share by Application (2021-2032)
- 7.3 Global IVIg Liquid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 IVIg Liquid Value Chain Analysis
- 8.1.1 IVIg Liquid Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 IVIg Liquid Production Mode & Process
- 8.2 IVIg Liquid Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 IVIg Liquid Distributors
- 8.2.3 IVIg Liquid Customers
9 Global IVIg Liquid Analyzing Market Dynamics
- 9.1 IVIg Liquid Industry Trends
- 9.2 IVIg Liquid Industry Drivers
- 9.3 IVIg Liquid Industry Opportunities and Challenges
- 9.4 IVIg Liquid Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst